[1]
|
J. S. Dysart, M. S. Patterson, T. J. Farrell, et a1. Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochemistry and Photo-biology, 2002, 75(2): 289-295.
|
[2]
|
J. Tyrrell, S. M. Campbell and A. Curnow. Monitoring the accumulation and dissipation of the photosen-sitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photo- dynamic therapy utilizing noninvasive fluorescence imaging and quantification. Photodiagnosis and Photo-dynamic Therapy, 2011, 8(1): 30-38.
|
[3]
|
C. P. Chang, D. J. Nagel and M. E. Zaghloul. Irradiance dependence of photobleaching of resorufin. Journal of Photochemistry and Photobiology A: Chemistry, 2011, 217(2): 430-432.
|
[4]
|
J. S. Dysart, G. Singh and M. S. Patterson. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochemistry and Photobiology, 2005, 81(1): 196–205.
|
[5]
|
J. S. Dysart, M. S. Patterson. Characterization of photofrin photo- bleach-ing for singlet oxygen dose estimation buring photodynamic therapy of MLL cells in vitro. Physics in Medicine and Biology, 2005, 50(11): 2597-2616.
|
[6]
|
W. S. Strauss, R. Sailer, M. H. Gschwend, et a1. Selective examination of plasma membrane associated photosensitizers Using total internal reflection fuorescence spectroscopy: Correlation between photobleaching and photodynamic efficacy of protoporphyrin IX. Photochemistry and Photobiology, 1998, 67(3): 363-369.
|
[7]
|
P. M. Msc, A. Juzenierea and J. Moan. The effect of lidocaine on PpIX photobleaching and outcome of ALA-PDT in vitro. Photodiagnosis and Photodynamic Therapy, 2007, 4(4): 249-253.
|
[8]
|
I. A. Boere, D. J. Robinson, H. W. Tilanus, et a1. Monitoring in situ dosimetry and pro-toporphyrin IX fuorescence photobleaching in the normal rat esopha-gus during 5-aminolevulinic acid photodynamic therapy. Photochemis-try and Photobiology, 2003, 78(3): 271-277.
|
[9]
|
H. Zeng, M. Korbelik, D. I. Mclean, et a1. Monitoring photoproduct formation and photobleaching by fuorescence spectroscopy has the potential to improve PDT dosimetry with a verte- porfin-like photosensitizer. Photochemistry and Photobiology, 2002, 75(4): 398-405.
|
[10]
|
J. Moan, G. Streckyte, S. Bagdonas, et a1. Photobleaching of protoporphyrin IX in cells incu-bated with 5-aminolevulinic acid. International Journal of Cancer, 1997, 70(1): 90-97.
|
[11]
|
J. Tyrrell, S. M. Campbell and A. Curnow. Pro-toporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy. Photodiagnosis and Photodynamic Therapy, 2010, 7(4): 232-238.
|
[12]
|
熊建文, 肖化, 张镇西. MTT法和CCK-8法检测细胞活性之测试条件比较[J]. 激光生物学报, 2007, 16(5): 526-531.
|
[13]
|
张镇西, 张苏娟, 张宝琴等. 氨基酮戊酸光动力学疗法杀伤白血病细胞的实验研究[J]. 中国激光医学杂志, 2005, 14(4): 249-252.
|
[14]
|
肖化, 熊建文, 吴继明等. ALA-PDT对白血病肿瘤细胞作用的参数研究[J]. 激光生物学报, 2004, 13(5): 353-357.
|
[15]
|
M. B. Ericson, F. Gudmundson, A. M. Wennberg, et al. A spectroscopic study of the photobleaching of protoporphyrin IX in solution. Lasers in Medical Science, 2004, 18(1): 56-62.
|
[16]
|
J. Tyrrell, S. M. Campbell and A. Curnow. The effect of air cooling pain relief on protoporphyrin IX photobleaching and clini-cal efficacy during bermatological photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology, 2011, 103(1): 1-7.
|
[17]
|
J. Moan and K. Berg. The photodegradation of porphyrins in cells can be used to estimate the lifetime of snglet oxygen. Pho- to-chemistry and Photobiology, 1991, 53 (4): 549-553.
|
[18]
|
S. Bagdonas, L. W. Ma, P. Juzenas, et al. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: A spectroscopic study. Photo-chemistry and Photobiology, 2000, 72(2): 186-192.
|